Current Net Margin
-6093.77%
Keros Therapeutics, Inc. currently has a net profit margin of -6093.77%.
Financial Fundamentals
KROS • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.00 | -0.02 | -6093.77% | ▼604272 |
| 2025-09-30 | 0.01 | -0.01 | -51.04% | ▲11791 |
| 2025-06-30 | 0.02 | -0.03 | -168.96% | ▼23923 |
| 2025-03-31 | 0.21 | 0.15 | 70.27% | ▲158329 |
| 2024-12-31 | 0.00 | -0.05 | -1513.02% | ▲1213544 |
| 2024-09-30 | 0.00 | -0.05 | -13648.45% | ▲10866776 |
| 2024-06-30 | 0.00 | -0.05 | -122316.22% | ▼7037164 |
| 2024-03-31 | 0.00 | -0.04 | -51944.58% | ▼2380262 |
| 2023-12-31 | 0.00 | -0.04 | -28141.96% | ▲46485804 |
| 2023-09-30 | 0.00 | -0.04 | -493000.00% | — |
| 2023-06-30 | 0.00 | -0.04 | — | — |
| 2023-03-31 | 0.00 | -0.04 | — | — |
| 2022-12-31 | 0.00 | -0.03 | — | — |
| 2022-09-30 | 0.00 | -0.02 | — | — |
| 2022-06-30 | 0.00 | -0.03 | — | — |
| 2022-03-31 | 0.00 | -0.02 | — | — |
| 2021-12-31 | 0.02 | -0.01 | -34.70% | — |
| 2021-09-30 | 0.00 | -0.02 | — | — |
| 2021-06-30 | 0.00 | -0.02 | -15622.00% | — |
| 2021-03-31 | 0.00 | -0.02 | — | — |
| 2020-12-31 | 0.00 | -0.01 | — | — |
| 2020-09-30 | 0.00 | -0.01 | — | — |
| 2020-06-30 | 0.00 | -0.01 | — | — |
| 2020-03-31 | 0.00 | -0.01 | — | — |
| 2019-12-31 | 0.00 | -0.00 | -110.04% | ▲3192 |
| 2019-09-30 | 0.00 | -0.00 | -141.96% | ▼2784 |
| 2019-06-30 | 0.00 | -0.00 | -114.12% | ▲1320 |
| 2019-03-31 | 0.00 | -0.00 | -127.32% | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.